Advances in trichomoniasis

( views:1299, downloads:0 )
ZHAO Yu-lei(Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China)
SU Xiao-hong(Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China)
Journal Title:
International Journal of Dermatology and Venereology
Volume 38, Issue 05, 2012
Key Word:
Trichomonas vaginalis; Epidemiology; Sexually transmitted diseases

Abstract´╝Ü Trichomoniasis is a highly prevalent sexually transmitted disease worldwide,which is often asymptomatic and has been associated with potentially serious sequelae.Recent genomic and proteomic studies have identified several protein families and novel surface proteins involved in host-pathogen interactions and trichomoniasis pathogenesis.Advances in molecular techniques for trichomoniasis diagnosis have led to a better understanding of the epidemiology of Trichomonas vaginalis infection,as well as of the interactions between T.vaginalis and other sexually transmitted disease pathogens.Trichomoniasis is poorly controlled at present and there has been increasing levels of drug resistance in T.vaginalis recently.Screening is strongly recommended for populations at high risk.

  • [1]World Health Organization.Prevalence and incidence of selected sexually transmitted infections Chlamydia trachomatis,Neisseria gonorrhoeae,syphilis and Trichomonas vaginalis.Methods and results used by WHO to generate 2005 estimates.Geneva:WHO,2011:1-36.
  • [2]Miller WC,Swygard H,Hobbs MM,et al.The prevalence of trichomoniasis in young adults in the United States.Sex Transm Dis,2005,32(10):593-598.
  • [3]Poon AN,Li Z,Wang N,Hong Y.Review of HIV and other sexually transmitted infections among female sex workers in China.AIDS Care,2011,23(Suppl 1):5-25.
  • [4]Crucitti T,Jespers V,Mulenga C,et al.Trichomonas vaginalis is highly prevalent in adolescent girls,pregnant women,and commercial sex workers in Ndola,Zambia.Sex Transm Dis,2010,37(4):223-227.
  • [5]Gollub EL,Armstrong K,Boney T,et al.Correlates of trichomonas prevalence among street-recruited,drug-using women enrolled in a randomized trial.Subst Use Misuse,2010,45 (13):2203-2220.
  • [6]Sutton M,Sternberg M,Koumans EH,et al.The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States,2001-2004.Clin Infect Dis,2007,45 (10):1319-1326.
  • [7]Leon SR,Konda KA,Bernstein KT,et al.Trichomonas vaginalis infection and associated risk factors in a socially-marginalized female population in coastal Peru.Infect Dis Obstet Gynecol,2009,2009:752437.
  • [8]Madhivanan P,Bartman MT,Pasutti L,et al.Prevalence of Trichomonas vaginalis infection among young reproductive age women in India:implications for treatment and prevention.Sex Health,2009,6(4):339-344.
  • [9]Bastida-Corcuera FD,Okumura CY,Colocoussi A,et al.Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells.Eukaryot Cell,2005,4 (11):1951-1958.
  • [10]Ardalan S,Lee BC,Garber GE.Trichomonas vaginalis:the adhesins AP51 and AP65 bind heme and hemoglobin.Exp Parasitol,2009,121(4):300-306.
  • [11]Ryan CM,de Miguel N,Johnson PJ.Trichomonas vaginalis:current understanding of host-parasite interactions.Essays Biochem,2011,51:161-175.
  • [12]Huppert JS,Biro F,Lan D,et al.Urinary symptoms in adolescent females:STI or UTI? J Adolesc Health,2007,40(5):418-424.
  • [13]Kaul P,Gupta I,Sehgal R,et al.Trichomonas vaginalis:random amplified polymorphic DNA analysis of isolates from symptomatic and asymptomatic women in India.Parasitol Int,2004,53 (3):255-262.
  • [14]Yadav M,Dubey ML,Gupta I,et al.Cysteine proteinase 30 in clinical isolates of T.vaginalis from symptomatic and asymptomatic infected women.Exp Parasitol,2007,116(4):399-406.
  • [15]Yadav M,Gupta I,Malla N.Kinetics of immunoglobulin G,M,A and IgG subclass responses in experimental intravaginal trichomoniasis:prominence of IgG1 response.Parasite Immunol,2005,27(12):461-467.
  • [16]Kissinger P,Amedee A,Clark RA,et al.Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.Sex Transm Dis,2009,36(1):11-16.
  • [17]Chapin K,Andrea S.APTIMA? Trichomonas vaginalis,a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens.Expert Rev Mol Diagn,2011,11(7):679-688.
  • [18]Malla N,Kaul P,Sehgal R,et al.The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.Indian J Med Microbiol,2011,29 (2):152-157.
  • [19]Gatski M,Kissinger P.Observation of probable persistent,undetected Trichomonas vaginalis infection among HIV-positive women.Clin Infect Dis,2010,51 (1):114-115.
  • [20]Meade JC,de Mestral J,Stiles JK,et al.Genetic diversity of Trichomonas vaginalis clinical isolates determined by EcoRI restriction fragment length polymorphism of heat-shock protein 70 genes.Am J Trop Med Hyg,2009,80(2):245-251.
  • [21]Conrad M,Zubacova Z,Dunn LA,et al.Microsatellite polymorphism in the sexually transmitted human pathogen Trichomonas vaginalis indicates a genetically diverse parasite.Mol Biochem Parasitol,2011,175(1):30-38.
  • [22]No(e)l C J,Diaz N,Sicheritz-Ponten T,et al.Trichomonas vaginalis vast BspA-like gene family:evidence for functional diversity from structural organisation and transcriptomics.BMC Genomics,2010,11:99.
  • [23]de Miguel N,Lustig G,Twu O,et al.Proteome analysis of the surface of Trichomonas vaginalis reveals novel proteins and strain-dependent differential expression.Mol Cell Proteomics,2010,9(7):1554-1566.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615